May 24 (Reuters) - Biomx Inc PHGE.A :
* BIOMX REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATES
* BIOMX INC - CONTINUES TO ANTICIPATE CLINICAL TRIAL
READOUTS IN
UP TO 4 DIFFERENT THERAPEUTIC INDICATIONS BY MID-2022
* BIOMX - EXISTING CASH, CASH EQUIVALENTS, SHORT-TERM
DEPOSITS TO
FUND CO'S CURRENT OPERATING PLAN, CAPEX REQUIREMENTS UNTIL AT
LEAST MID-2022
* BIOMX INC - NET LOSS FOR Q1 OF 2021 WAS $8.4 MILLION,
COMPARED
TO $5.9 MILLION FOR SAME PERIOD IN 2020
Source text for Eikon: ID:nBwbjMKTda
Further company coverage: PHGE.A
((Reuters.Briefs@thomsonreuters.com;))